Literature DB >> 234658

BCG and cancer prevention.

M B Shimkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234658      PMCID: PMC1130326     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  7 in total

1.  Immunological aspects of malignant disease.

Authors:  F M Burnet
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

2.  Granulomatous hepatitis: a complication of B.C.G. immunotherapy.

Authors:  J S Hunt; M J Silverstein; F C Sparks; C M Haskell; Y H Pilch; D L Morton
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

3.  Leukaemia and B.C.G. A controlled trial.

Authors:  G W Comstock
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

4.  B.C.G. vaccination and leukemia mortality.

Authors:  L Davignon; P Robillard; P Lemonde; A Frappier
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

5.  Parallels, convergences, and departures in case-control studies and clinical trials.

Authors:  M A Schneiderman; D L Levin
Journal:  Cancer Res       Date:  1973-06       Impact factor: 12.701

6.  BCG vaccination and leukemia mortality.

Authors:  S R Rosenthal; R G Crispen; M G Thorne; N Piekarski; N Raisys; P G Rettig
Journal:  JAMA       Date:  1972-12-18       Impact factor: 56.272

7.  Yellow pigments excreted by vitamin A-depleted sheep.

Authors:  R E Tucker; G E Mitchell; C O Little
Journal:  J Nutr       Date:  1967-12       Impact factor: 4.798

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.